Traws Pharma, Inc. Logo

Traws Pharma, Inc.

Clinical-stage biopharma developing oral therapies for respiratory viral diseases.

TRAW | US

Overview

Corporate Details

ISIN(s):
US68232V8845 (+1 more)
LEI:
Country:
United States of America
Address:
12 PENNS TRAIL, 18940 NEWTOWN

Description

Traws Pharma, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel oral small-molecule therapies for respiratory viral diseases. The company focuses on advancing investigational antiviral agents with potent activity against difficult-to-treat or resistant virus strains. Its pipeline includes two lead candidates: ratutrelvir, a ritonavir-independent antiviral targeting the Main protease (Mpro) for the treatment of COVID-19 and Long COVID, and tivoxavir marboxil, a single-dose antiviral targeting the influenza cap-dependent endonuclease (CEN) for the treatment and prevention of bird flu and seasonal influenza. The company aims to develop safe product candidates with simple dosing regimens.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-17 12:00
FORM 8-K
English ZIP 116.2 KB
2025-12-17 00:23 English ZIP 7.3 KB
2025-12-17 00:22 English ZIP 7.1 KB
2025-12-17 00:21 English ZIP 7.2 KB
2025-12-17 00:20 English ZIP 7.2 KB
2025-12-17 00:20 English ZIP 7.3 KB
2025-12-17 00:17 English ZIP 7.3 KB
2025-12-17 00:16 English ZIP 7.2 KB
2025-12-17 00:15 English ZIP 7.1 KB
2025-12-17 00:14 English ZIP 7.3 KB
2025-12-16 23:00
FORM 8-K
English ZIP 65.3 KB
2025-11-28 22:30
FORM 8-K
English ZIP 153.6 KB
2025-11-26 00:53 English ZIP 7.1 KB
2025-11-14 22:00 English ZIP 9.8 KB
2025-11-14 20:29 English ZIP 100.3 KB

Automate Your Workflow. Get a real-time feed of all Traws Pharma, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Traws Pharma, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Traws Pharma, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.